Kihong Kim is the lead scientist and associate director of the Antibody Technology Discovery group at Samsung Biologics’ Bio R&D Center. He joined the company in 2024, bringing over 14 years of experience in biopharmaceutical development, with a particular focus on advancing biologics from discovery through to the preclinical stage. Throughout his career, he has gained deep expertise in areas such as antibody design and engineering to enhance efficacy, pharmacokinetics, and the purity of bsAbs; fusion proteins; antibody-drug conjugates; and antibody platforms, including technologies that penetrate the blood-brain barrier. At Samsung Biologics, he has made notable contributions to various antibody discovery platforms, including the development of S-KiH and S-DUAL®.